| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.089 | 0.009 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.17 | 0.01 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.072 | 0.01 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.01 |